|
Jun 20
|
CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech
|
|
Jun 13
|
Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz
|
|
Jun 12
|
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
|
|
Jun 12
|
Gold prices, BioNTech to acquire CureVac, Tapestry upgrade
|
|
Jun 12
|
Top Midday Stories: Boeing Shares Fall After Air India Plane Crash; Oracle Q4 Results Top Expectations
|
|
Jun 12
|
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments
|
|
Jun 12
|
BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business
|
|
Jun 12
|
BioNTech to Acquire CureVac in $1.25 Billion All-Stock Deal
|
|
Jun 12
|
BioNTech buys mRNA, courtroom rival CureVac in all-stock deal
|
|
Jun 12
|
BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion
|
|
Jun 12
|
CureVac stock soars about 30% after BioNTech agrees to acquire co
|
|
Jun 12
|
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
|
|
Jun 12
|
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
|
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
|
Jun 10
|
Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee
|
|
Jun 10
|
RFK Jr. removes CDC vaccine panel members: What to know
|
|
May 27
|
BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
|
|
May 21
|
BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion
|
|
May 21
|
MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots
|
|
May 21
|
BioNTech to invest up to $1.34bn in UK R&D
|